ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KEVIN GANONG M.D.

Endocrinology, Diabetes Metabolism

8,060

$924K

724
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 43%

$115
Average prescription price

Avg: $104

ALLEN REDDING M.D.

Endocrinology, Diabetes Metabolism

7,398

$781K

543
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 43%

$106
Average prescription price

Avg: $104

RICHARD RAPP M.D.

Endocrinology, Diabetes Metabolism

5,597

$503K

347
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 43%

$90
Average prescription price

Avg: $104

ADAM MAASS MD

Endocrinology, Diabetes Metabolism

5,400

$714K

480
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 43%

$132
Average prescription price

Avg: $104

TIMOTHY BOEHM M.D.

Endocrinology, Diabetes Metabolism

4,632

$373K

390
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 43%

$81
Average prescription price

Avg: $104

CECILLIA TSAO MD

Endocrinology, Diabetes Metabolism

4,142

$209K

268
127 are 65+

22%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 43%

$50
Average prescription price

Avg: $104

ZULEKHA HAMID MD

Endocrinology, Diabetes Metabolism

4,120

$411K

339
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 43%

$100
Average prescription price

Avg: $104

PAUL HOWELL MD

Endocrinology, Diabetes Metabolism

3,723

$374K

400
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 43%

$101
Average prescription price

Avg: $104

RICHARD GRIFFITHS M.D.

Endocrinology, Diabetes Metabolism

3,643

$463K

294
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 43%

$127
Average prescription price

Avg: $104

RAYMOND MARECEK MD

Endocrinology, Diabetes Metabolism

3,608

$257K

214
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 43%

$71
Average prescription price

Avg: $104

GANESH NAIR M.D.

Endocrinology, Diabetes Metabolism

3,298

$378K

296
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 43%

$115
Average prescription price

Avg: $104

NIDHI JAIN MD

Endocrinology, Diabetes Metabolism

3,285

$370K

291
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 43%

$113
Average prescription price

Avg: $104

DEBORAH BURSEY M.D.

Endocrinology, Diabetes Metabolism

2,769

$260K

247
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 43%

$94
Average prescription price

Avg: $104

MADHU BUDHRAJA MD

Endocrinology, Diabetes Metabolism

2,515

$216K

231
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 43%

$86
Average prescription price

Avg: $104

DARYL BURROWS MD

Endocrinology, Diabetes Metabolism

2,397

$296K

220
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 43%

$123
Average prescription price

Avg: $104

LYNDELL HORINE MD

Endocrinology, Diabetes Metabolism

1,867

$217K

200
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 43%

$116
Average prescription price

Avg: $104

IRINA LENDEL MD

Endocrinology, Diabetes Metabolism

1,790

$223K

344
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 43%

$125
Average prescription price

Avg: $104

TERESA NIMMO MD

Endocrinology, Diabetes Metabolism

1,784

$254K

194
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 43%

$142
Average prescription price

Avg: $104

NADINE ALEX MD

Endocrinology, Diabetes Metabolism

1,761

$209K

109
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 43%

$119
Average prescription price

Avg: $104

DONALD BODENNER MD

Endocrinology, Diabetes Metabolism

1,428

$181K

200
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 43%

$127
Average prescription price

Avg: $104

CATHERINE KILPATRICK M.D.

Endocrinology, Diabetes Metabolism

959

$75.3K

62
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 43%

$79
Average prescription price

Avg: $104

NUTTHA UNGNAPATANIN M.D.

Endocrinology, Diabetes Metabolism

551

$87.9K

109
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 43%

$160
Average prescription price

Avg: $104

CASTRO BALI

Endocrinology, Diabetes Metabolism

544

$20.8K

44
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 43%

$38
Average prescription price

Avg: $104

JONATHAN STRINGER MD

Endocrinology, Diabetes Metabolism

492

$62.3K

124
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 43%

$127
Average prescription price

Avg: $104

SHUNZHONG BAO M.D.

Endocrinology, Diabetes Metabolism

417

$38.1K

77
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 43%

$91
Average prescription price

Avg: $104

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank